CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 2.109
AS - Asia 1.241
EU - Europa 1.039
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 28
OC - Oceania 2
Totale 4.642
Nazione #
US - Stati Uniti d'America 2.020
SG - Singapore 491
IT - Italia 420
CN - Cina 287
BR - Brasile 152
DE - Germania 143
BD - Bangladesh 133
FI - Finlandia 117
HK - Hong Kong 112
GB - Regno Unito 66
VN - Vietnam 64
FR - Francia 56
UA - Ucraina 54
CA - Canada 49
RU - Federazione Russa 43
IN - India 39
TR - Turchia 32
NL - Olanda 30
PL - Polonia 27
IE - Irlanda 24
MX - Messico 17
JP - Giappone 11
AR - Argentina 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
SE - Svezia 9
BE - Belgio 8
ES - Italia 8
PK - Pakistan 8
AT - Austria 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
TW - Taiwan 6
VE - Venezuela 6
ID - Indonesia 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
AL - Albania 3
AZ - Azerbaigian 3
CO - Colombia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
IL - Israele 3
KR - Corea 3
NP - Nepal 3
SV - El Salvador 3
UZ - Uzbekistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
EC - Ecuador 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.600
Città #
Singapore 300
Ashburn 293
San Jose 155
Fairfield 128
Hong Kong 112
Helsinki 94
Council Bluffs 84
New York 78
Milan 72
Woodbridge 65
Los Angeles 64
The Dalles 64
Houston 62
Beijing 61
Seattle 53
Wilmington 51
Munich 47
Cambridge 46
Brescia 45
Jacksonville 44
Ann Arbor 40
Chandler 36
Dallas 32
Lauterbourg 29
Santa Clara 29
Istanbul 25
Warsaw 25
Dublin 24
Nanjing 24
Princeton 24
Ho Chi Minh City 23
Chicago 21
Columbus 20
Turku 20
Buffalo 18
São Paulo 18
Montreal 17
Rome 17
Dearborn 16
Denver 16
Redondo Beach 15
Orem 14
Des Moines 13
Frankfurt am Main 13
Hanoi 13
Moscow 13
San Francisco 13
London 12
Phoenix 12
Mumbai 11
Shanghai 11
Toronto 11
Nuremberg 10
Chennai 9
North Bergen 9
Turin 9
Bologna 8
Boston 8
Jinan 8
Mexico City 8
Naples 8
Stockholm 8
Verona 8
Washington 8
Brussels 7
Guangzhou 7
Tokyo 7
Amsterdam 6
Atlanta 6
Brasília 6
Charlotte 6
Düsseldorf 6
Florence 6
Monza 6
Poplar 6
Riyadh 6
Boardman 5
Castelli Calepio 5
Changsha 5
Da Nang 5
Elk Grove Village 5
Hangzhou 5
Johannesburg 5
Nanchang 5
Ningbo 5
Palermo 5
Philadelphia 5
Rio de Janeiro 5
Salò 5
San Giuliano Terme 5
San José 5
Taipei 5
Taranto 5
Amman 4
Ardabil 4
Augusta 4
Bagnolo Mella 4
Bolingbrook 4
Chapel Hill 4
Figino 4
Totale 2.832
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 380
COVID-19 impact on consecutive neurological patients admitted to the emergency department 273
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 257
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 243
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 242
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 191
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 190
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 185
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 175
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 168
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 147
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 147
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 142
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 121
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 113
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 112
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 108
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 107
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 106
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 103
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 102
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 101
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 101
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 98
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 97
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 93
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 93
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 83
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 81
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 80
Photophobia and migraine outcome during treatment with galcanezumab 70
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 67
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 66
Totale 4.642
Categoria #
all - tutte 19.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 0 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/20262.093 155 190 119 235 193 195 346 122 132 170 102 134
2026/2027507 93 81 134 199 0 0 0 0 0 0 0 0
Totale 4.642